DR. REDDY'S LABORATORIES LIMITED |
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 69.53 USD | -0.11% |
|
+1.86% | -0.07% |
ETFs positioned on Dr. Reddy's Laboratories Limited
| Name | Weight | AuM | 1st Jan change | Investor Rating |
|---|---|---|---|---|
| 3.69% | 96 M€ | -.--% | - | |
| 1.76% | 11 M€ | -.--% | - | |
| 0.56% | 19 M€ | +8.91% | ||
| 0.27% | 17 M€ | 0.00% | ||
| 0.01% | 112 M€ | +4.59% | - | |
| 0.00% | 34 M€ | +4.20% | - |
Dr. Reddy's Laboratories specializes in developing, producing, and selling pharmaceutical products. Net sales break down by activity as follows:
- sales of generic medications (79.9%): brand-name or generic prescription medications and OTC medicines;
- sales of active ingredients (15.7%). The group also supplies customized pharmaceutical services;
- other (4.4%): sales of generic biopharmaceutical products, development of molecular agents, etc.
Net sales are distributed geographically as follows: India (18.8%), the United States (45%), Russia (9.9%) and other (26.3%).
Sector
Pharmaceuticals
Calendar
15/07/2024
- Ex-dividend day for final dividend
Trading Rating
Investor Rating
ESG Refinitiv
Sell
Buy
Mean consensus
HOLD
Number of Analysts
35
Last Close Price
5,884
INR
Average target price
6,101
INR
Spread / Average Target
+3.68%
EPS Revisions
| 1st Jan change | Capi. | |
|---|---|---|
| +38.51% | 727B | |
| +31.74% | 599B | |
| -6.23% | 354B | |
| +18.78% | 328B | |
| +1.35% | 277B | |
| +16.00% | 243B | |
| +8.44% | 205B | |
| -5.97% | 203B | |
| +6.19% | 164B |
- Stock Market
- Equities
- DRREDDY Stock
- RDY Stock
- Funds and ETFs Dr. Reddy's Laboratories Limited
